Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edgewise Therapeutics (EWTX) Change in Accured Expenses (2020 - 2026)

Edgewise Therapeutics has reported Change in Accured Expenses over the past 7 years, most recently at $635000.0 for Q1 2026.

  • Quarterly results put Change in Accured Expenses at $635000.0 for Q1 2026, up 420.49% from a year ago — trailing twelve months through Mar 2026 was $2.9 million (up 108.9% YoY), and the annual figure for FY2025 was $2.4 million, up 105.01%.
  • Change in Accured Expenses reached $635000.0 in Q1 2026 per EWTX's latest filing, down from $4.4 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $4.4 million in Q4 2025 and bottomed at -$2.0 million in Q1 2023.
  • Median Change in Accured Expenses over the past 5 years was $635000.0 (2026), compared with a mean of $415588.2.
  • The largest annual shift saw Change in Accured Expenses plummeted 228.35% in 2024 before it soared 564.47% in 2025.
  • Over 5 years, Change in Accured Expenses stood at $1.4 million in 2022, then rose by 7.08% to $1.5 million in 2023, then plummeted by 56.32% to $667000.0 in 2024, then skyrocketed by 564.47% to $4.4 million in 2025, then crashed by 85.67% to $635000.0 in 2026.
  • Business Quant data shows Change in Accured Expenses for EWTX at $635000.0 in Q1 2026, $4.4 million in Q4 2025, and -$765000.0 in Q3 2025.